Through targeted outreach activities, MSF teams engaged with people from high-risk groups who would otherwise have difficulty accessing diagnosis, and medical and preventive care.
We also supported the diagnosis and treatment of people living with HIV and co-infections at Tashkent AIDS centre.
Data and information from the International Activity Report 2024.
In Karakalpakstan, in the west of the country, MSF ran a comprehensive care programme for patients with drug-resistant forms of TB.
We ensured that all eligible patients with multidrug-resistant TB (MDR-TB) in Karakalpakstan receive treatment using the latest, all-oral, six-month regimen. In the second half of the year, we expanded our MDR-TB support to the neighbouring Khorezm region.
In 2024, we also provided direct technical assistance on the treatment of patients with severe forms of extensively drug-resistant TB in Nukus TB hospital.
IN 2024
